Fusion Antibodies gears up for flotation on the AIM

The Belfast Telegraph has reported that CoFund portfolio company Fusion Antibodies is set to list on the AIM market.

The Belfast Telegraph has reported that CoFund portfolio company Fusion Antibodies is set to list on the AIM market.

Share the Post:

Related Posts

In Memory of Dr Alan Mawson

It is with great sadness that Clarendon marks the passing of Alan, a colleague, mentor and friend to so many across our firm and the wider venture capital community in Northern Ireland. Over 25 years he shaped not only Clarendon, but the careers and lives of countless people who had the privilege of working with him.

Read More